CD14 and hereditary angioedema: It was also noted for CD14++CD16+ cells during HAE attack (55.39%; 34.52–86.40%) compared to the remission state (42.15%; 26.25–61.40%; p = 0.0006) and healthy subjects (37.50%; 24.34–74.77%; p = 0.0005).